Question 1

Am I eligible for this trial based on my current health and cancer stage?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

Question 2

How does nivolumab compare to other treatments available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of nivolumab that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience a relapse after this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to participate in follow-up studies after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiation Free Chemotherapy for Early Hodgkin Lymphoma clinical trial (NCT04866654). Contact the study team or your healthcare provider for specific answers.

What this study is about